AVANTI POLAR LIPIDS, INC.
LIVE

Serial Number

88632780

Owner

AVANTI POLAR LIPIDS, LLC

Attorney

Patrick J. Jennings

First Use Date

May 1, 2002

Filing Date

Sep 26, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AVANTI POLAR LIPIDS, INC. Trademark

Serial Number: 88632780 • Registration: 7854388

AVANTI POLAR LIPIDS, INC. is a trademark filed by AVANTI POLAR LIPIDS, LLC on September 26, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AVANTI POLAR LIPIDS, LLC (23 trademarks)

ALABASTER, AL 35007

Entity Type: 16

AVANTI POLAR LIPIDS, INC. (28 trademarks)

ALABASTER, AL 350079105

Entity Type: 03

Trademark Details

Filing Date

September 26, 2019

Registration Date

July 8, 2025

First Use Anywhere

May 1, 2002

First Use in Commerce

May 1, 2002

Published for Opposition

May 20, 2025

Goods & Services

cGMP custom manufacture of active agents, additives, or excipients for others; cGMP custom manufacture of lipids for others; custom manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; custom manufacturing services for others in the field of lipids; providing information relating to the custom manufacture of lipids and chemical compounds for scientific and medical research purposes

Adjuvants for medical use; immunostimulatory compounds, namely, lipids for medical use; medical diagnostic reagents; test strips for the detection of bacterial infections for medical use; isotopes for medical use

Chemical compounds for scientific or research use; adjuvants for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; chemical compounds for use as standards for use with analytical techniques, namely, mass spectrometry; compounds for scientific or research use, namely, lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labeled lipids, oxidized lipids, sphingolipids, lipid extracts from natural sources, lipids conjugated with modified gold particles; compounds for scientific or research use, namely, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; diagnostic reagents and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; lipids, chemical additives, and excipients for use in the manufacture of pharmaceutical preparations

Analytical services, namely, performing nutraceutical testing, NMR analysis, mass spectrometry analysis, infrared spectroscopy analysis, chromatography analysis, gas chromatography analysis, particle size analysis, zeta potential analysis, thin layer chromatography analysis, water content analysis, peroxide oxidation and phosphorous content analysis, chemical stability testing, and development of chemical analytical methods; scientific research and medical research services; analytical services, namely, performing nutraceutical testing, NMR analysis, mass spectrometry analysis, infrared spectroscopy analysis, chromatography analysis, gas chromatography analysis, particle size analysis, zeta potential analysis, thin layer chromatography analysis, water content analysis, peroxide oxidation and phosphorous content analysis, chemical stability testing, and development of chemical analytical methods in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; scientific research and product development and consultation related thereto in the field of pharmaceuticals and chemicals; scientific research services for others; scientific research services for others in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; lipidomics services, namely, identification and quantification of lipid compounds in a sample, identification of protein-lipid interactions, and identifying the role of lipids in cellular signaling all in the nature of scientific research; cGMP testing services, namely, lipid raw material release testing, developing of testing specifications and standard operating procedures, quality assurance review, product testing, and chemical stability testing all in the field of pharmaceuticals, lipids and chemicals; formulation services, namely, development of standards for liposome and nanoparticle formulations, scaling-up manufacturing processes, and testing and development of standards for synthesis of lipid compounds for use in formulations, in the field of pharmaceuticals, lipids, and chemicals; providing information relating to chemical characterization, analysis methods, and uses of lipids and related compounds for scientific and medical research purpose

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 17, 2025 ERFR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Apr 11, 2025 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Apr 11, 2025 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Apr 11, 2025 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 4, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 14, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 14, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 14, 2025 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 2, 2024 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 29, 2024 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 29, 2023 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 2, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 7, 2022 RCSC
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 24, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 24, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 24, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 24, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 24, 2022 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 21, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 20, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 25, 2021 RCSC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 4, 2020 ASGN
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 29, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 29, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jul 29, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 3, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2019 NWOS
NEW APPLICATION ENTERED
Sep 30, 2019 NWAP